These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 26661780)

  • 41. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
    Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
    Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plant-made vaccine antigens and biopharmaceuticals.
    Daniell H; Singh ND; Mason H; Streatfield SJ
    Trends Plant Sci; 2009 Dec; 14(12):669-79. PubMed ID: 19836291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plants as bioreactors for the production of vaccine antigens.
    Tiwari S; Verma PC; Singh PK; Tuli R
    Biotechnol Adv; 2009; 27(4):449-67. PubMed ID: 19356740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporal perturbation of tyrosine phosphoproteome dynamics reveals the system-wide regulatory networks.
    Oyama M; Kozuka-Hata H; Tasaki S; Semba K; Hattori S; Sugano S; Inoue J; Yamamoto T
    Mol Cell Proteomics; 2009 Feb; 8(2):226-31. PubMed ID: 18815124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination.
    Nochi T; Takagi H; Yuki Y; Yang L; Masumura T; Mejima M; Nakanishi U; Matsumura A; Uozumi A; Hiroi T; Morita S; Tanaka K; Takaiwa F; Kiyono H
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10986-91. PubMed ID: 17573530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uniformity of environmental conditions and plant growth in a hydroponic culture system for use in a growth room with aerial CO2 control.
    Vessey JK; York EK; Henry LT; Raper CD
    Biotronics; 1988; 17():79-94. PubMed ID: 11537744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phytochrome-mediated control of COP1 gene expression in rice plants.
    Tsuge T; Inagaki N; Yoshizumi T; Shimada H; Kawamoto T; Matsuki R; Yamamoto N; Matsui M
    Mol Genet Genomics; 2001 Mar; 265(1):43-50. PubMed ID: 11370871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conservation of rice genetic resources: the role of the International Rice Genebank at IRRI.
    Jackson MT
    Plant Mol Biol; 1997 Sep; 35(1-2):61-7. PubMed ID: 9291960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cloning of cDNA encoding the rice 22 kDa protein of Photosystem II (PSII-S) and analysis of light-induced expression of the gene.
    Iwasaki T; Saito Y; Harada E; Kasai M; Shoji K; Miyao M; Yamamoto N
    Gene; 1997 Feb; 185(2):223-9. PubMed ID: 9055819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition.
    Dertzbaugh MT; Elson CO
    Infect Immun; 1993 Feb; 61(2):384-90. PubMed ID: 8423068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Out of darkness: mutants reveal pathways controlling light-regulated development in plants.
    Chory J
    Trends Genet; 1993 May; 9(5):167-72. PubMed ID: 8337753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral immunization with a recombinant bacterial antigen produced in transgenic plants.
    Haq TA; Mason HS; Clements JD; Arntzen CJ
    Science; 1995 May; 268(5211):714-6. PubMed ID: 7732379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.
    Kashima K; Yuki Y; Mejima M; Kurokawa S; Suzuki Y; Minakawa S; Takeyama N; Fukuyama Y; Azegami T; Tanimoto T; Kuroda M; Tamura M; Gomi Y; Kiyono H
    Plant Cell Rep; 2016 Mar; 35(3):667-79. PubMed ID: 26661780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel transgenic rice-based vaccines.
    Azegami T; Itoh H; Kiyono H; Yuki Y
    Arch Immunol Ther Exp (Warsz); 2015 Apr; 63(2):87-99. PubMed ID: 25027548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [MucoRice: development of rice-based oral vaccine].
    Yuki Y; Kiyono H
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):369-74. PubMed ID: 18974620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PaxVax CVD 103-HgR single-dose live oral cholera vaccine.
    Levine MM; Chen WH; Kaper JB; Lock M; Danzig L; Gurwith M
    Expert Rev Vaccines; 2017 Mar; 16(3):197-213. PubMed ID: 28165831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cholera as a model for research on mucosal immunity and development of oral vaccines.
    Holmgren J; Czerkinsky C
    Curr Opin Immunol; 1992 Aug; 4(4):387-91. PubMed ID: 1388838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
    Viret JF; Dietrich G; Favre D
    Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholera vaccines.
    Ryan ET; Calderwood SB
    Clin Infect Dis; 2000 Aug; 31(2):561-5. PubMed ID: 10987721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.